ATE412671T1 - Modifizierter faktor viii - Google Patents

Modifizierter faktor viii

Info

Publication number
ATE412671T1
ATE412671T1 AT03746308T AT03746308T ATE412671T1 AT E412671 T1 ATE412671 T1 AT E412671T1 AT 03746308 T AT03746308 T AT 03746308T AT 03746308 T AT03746308 T AT 03746308T AT E412671 T1 ATE412671 T1 AT E412671T1
Authority
AT
Austria
Prior art keywords
factor viii
fviii
modified
modified factor
immunogenic
Prior art date
Application number
AT03746308T
Other languages
English (en)
Inventor
Tim Jones
Matthew Baker
Francis Carr
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of ATE412671T1 publication Critical patent/ATE412671T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT03746308T 2002-04-18 2003-04-17 Modifizierter faktor viii ATE412671T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02008712 2002-04-18
EP03006554 2003-03-24

Publications (1)

Publication Number Publication Date
ATE412671T1 true ATE412671T1 (de) 2008-11-15

Family

ID=29252205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03746308T ATE412671T1 (de) 2002-04-18 2003-04-17 Modifizierter faktor viii

Country Status (15)

Country Link
US (1) US20050256304A1 (de)
EP (1) EP1495052B9 (de)
JP (1) JP2005538694A (de)
KR (1) KR20040103970A (de)
CN (1) CN1646564A (de)
AT (1) ATE412671T1 (de)
AU (1) AU2003232482A1 (de)
BR (1) BR0308860A (de)
CA (1) CA2482926A1 (de)
DE (1) DE60324406D1 (de)
ES (1) ES2319758T3 (de)
MX (1) MXPA04010061A (de)
PL (1) PL371278A1 (de)
RU (1) RU2004133761A (de)
WO (1) WO2003087161A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2526120A1 (en) 2003-06-03 2005-02-24 Cell Genesys, Inc. Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
US7485291B2 (en) 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
NO20210454A1 (no) 2004-11-12 2007-06-27 Bayer Healthcare Llc Setedirigert modifikasjon av FVIII
WO2006063031A2 (en) 2004-12-06 2006-06-15 Haplomics Allelic variants of human factor viii
FR2913020B1 (fr) * 2007-02-23 2012-11-23 Biomethodes Nouveaux facteurs viii pour le traitement des hemophiles de type a
WO2008157776A2 (en) * 2007-06-21 2008-12-24 Angelica Therapeutics, Inc. Modified diphtheria toxins
GB0723712D0 (en) * 2007-12-04 2008-01-16 Apitope Technology Bristol Ltd Peptides
GB0801513D0 (en) * 2008-01-28 2008-03-05 Circassia Ltd Peptides from factor VIII
EP2268297A4 (de) * 2008-02-29 2011-11-16 Angelica Therapeutics Inc Modifizierte toxine
GB0908515D0 (en) * 2009-05-18 2009-06-24 Apitope Technology Bristol Ltd Peptide
EP2742949A1 (de) * 2009-11-13 2014-06-18 Puget Sound Blood Center Faktor-VIII-B-Zellen-Epitopvarianten mit reduzierter Immunogenität
BR112012017483A2 (pt) * 2010-01-14 2019-09-24 Haplomics Inc previsão e redução de aloimunogenicidade de terapêuticos de proteína
TW201708251A (zh) * 2010-10-27 2017-03-01 巴克斯歐塔公司 用於免疫耐受誘導及免疫診斷之ｆｖｉｉｉ胜肽
EP2666782A1 (de) * 2012-05-22 2013-11-27 Imnate Sarl Gerinnungsfaktor VII mit reduzierter Immunogenität
US10272163B2 (en) 2012-12-07 2019-04-30 The Regents Of The University Of California Factor VIII mutation repair and tolerance induction
BR112015023793A2 (pt) * 2013-03-15 2017-07-18 Us Dept Veterans Affairs composições e métodos de terapias para indução de tolerância imune a substituição do fator vii em indivíduos com hemofilia a
CN105209488A (zh) * 2013-03-15 2015-12-30 拜耳医药保健有限公司 变体因子viii多肽及其产生和使用方法
EP2968450A4 (de) 2013-03-15 2016-10-26 Angelica Therapeutics Inc Modifizierte toxine
JP2021520802A (ja) * 2018-04-12 2021-08-26 ビオテスト・アクチエンゲゼルシャフトＢｉｏｔｅｓｔ ＡＧ 脱免疫化された第ｖｉｉｉ因子分子およびそれを含む医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180371B1 (en) * 1996-06-26 2001-01-30 Emory University Modified factor VIII
US20020068303A1 (en) * 1994-07-14 2002-06-06 Ruth Laub Antigenic polypeptide sequences of factor VIII, and fragments and/or epitopes of these sequences
BE1008491A3 (fr) * 1994-07-14 1996-05-07 Croix Rouge De Belgique Depart Sequence polypeptidique antigenique du facteur viii, fragments et/ou epitopes de celle-ci.
AU6486196A (en) * 1995-07-11 1997-02-10 Chiron Corporation Novel factor viii:c polypeptide analogs with altered protease sites
ES2258817T3 (es) * 1997-05-21 2006-09-01 Biovation Limited Metodo para la produccion de proteinas no inmunogenas.
GB9712892D0 (en) * 1997-06-20 1997-08-20 Eclagen Ltd Identification of mhc binding peptides
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
US6759216B1 (en) * 1998-11-06 2004-07-06 Emory University Glycosylated, low antigenicity low immunogenicity factor VIII
ATE352559T1 (de) * 1998-12-08 2007-02-15 Biovation Ltd Verfahren zur verminderung der immunogenität von proteinen
WO2002096454A1 (en) * 2001-05-31 2002-12-05 D. Collen Research Foundation Vzw Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools

Also Published As

Publication number Publication date
ES2319758T3 (es) 2009-05-12
CA2482926A1 (en) 2003-10-23
RU2004133761A (ru) 2005-07-10
EP1495052B9 (de) 2009-12-16
CN1646564A (zh) 2005-07-27
WO2003087161A1 (en) 2003-10-23
JP2005538694A (ja) 2005-12-22
KR20040103970A (ko) 2004-12-09
AU2003232482A1 (en) 2003-10-27
DE60324406D1 (de) 2008-12-11
PL371278A1 (en) 2005-06-13
EP1495052B1 (de) 2008-10-29
BR0308860A (pt) 2005-01-04
EP1495052A1 (de) 2005-01-12
US20050256304A1 (en) 2005-11-17
MXPA04010061A (es) 2004-12-13

Similar Documents

Publication Publication Date Title
ATE412671T1 (de) Modifizierter faktor viii
MXPA04001982A (es) Factor ix modificado.
AU2002302255A1 (en) Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
MXPA02005576A (es) Vacuna para la prevencion y tratamiento de la enfermedad de alzheimer y otras enfermedades relacionadas con amiloides.
EP3533461A3 (de) Von prame abstammende peptide und immunogene zusammensetzungen damit
AU2003242305A1 (en) Hla-a24-restricted cancer antigen peptide
HK1101131A1 (en) Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients
MXPA04004417A (es) Anticuerpo anti-tnf alfa modificado.
ATE319745T1 (de) Verfahren zur herstellung von nicht-immunogenen proteinen
PL366826A1 (en) Reducing the immunogenicity of fusion proteins
HUP0400700A2 (hu) Csökkentett immunogenitású, módosított humán agyi eredetű neutróf faktor (BDNF)
EA201070681A1 (ru) Пептиды fviii и их применение для индукции толерантности у больных гемофилией
WO2006023598A3 (en) Prostate-specific antigen-derived mhc class ii-restricted peptides and their use in vaccines to treat or prevent prostate cancer
DE60322225D1 (en) T-zellen-epitope in erythropoietin
HUP0402071A2 (hu) Csökkentett immunogenitású, módosított leptin
ATE177843T1 (de) Peptomere mit erhöhter immunogenizität
HUP0400703A2 (hu) Csökkentett immunogenitású módosított eritropoietin (EPO)
MXPA04001976A (es) Hormona de crecimiento humano modificada.
HUP0303430A2 (hu) Csökkentett immunogenitású, módosított protamin
EP1499349A4 (de) Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens
DE602005015368D1 (de) Immunogenes polypeptid bestehend aus optimierten kryptischen peptiden aus tumorantigenen und seine verwendungen
MXPA04004970A (es) Epitopos de linfocitos t en carboxipeptidasa g2.
BR0311308A (pt) Briodina 1 modificada com imunogenicidade reduzida
HUP0303150A2 (hu) Csökkentett immunogenitású, módosított keratinocita növekedési faktor (KGF)
HUP0401121A2 (hu) Csökkentett immunogenitású, módosított trombopoietin (TPO)

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties